Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1966 3
1967 3
1968 4
1969 3
1970 1
1971 5
1972 7
1973 7
1974 21
1975 24
1976 31
1977 30
1978 36
1979 40
1980 55
1981 62
1982 41
1983 62
1984 41
1985 49
1986 70
1987 57
1988 65
1989 89
1990 121
1991 140
1992 116
1993 125
1994 132
1995 120
1996 140
1997 133
1998 150
1999 170
2000 177
2001 163
2002 136
2003 191
2004 159
2005 187
2006 175
2007 219
2008 199
2009 216
2010 234
2011 248
2012 263
2013 269
2014 285
2015 314
2016 304
2017 280
2018 263
2019 270
2020 319
2021 316
2022 284
2023 240
2024 251
2025 267
2026 109

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7,739 results

Results by year

Filters applied: Meta-Analysis, Randomized Controlled Trial. Clear all
Page 1
Acetylsalicylic Acid (Aspirin) for Primary Prevention of Cardiovascular Events in Patients with Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Liu S, Eckstein J, Lam A, Cheema AN. Liu S, et al. Curr Vasc Pharmacol. 2023;21(2):111-119. doi: 10.2174/1570161121666230131120544. Curr Vasc Pharmacol. 2023. PMID: 36718966
BACKGROUND: Evidence regarding using acetylsalicylic acid (aspirin) for the prevention of cardiovascular (CV) events in patients with diabetes mellitus (DM) is inconsistent. ...Major bleeding was significantly higher for aspirin compared with placebo ( …
BACKGROUND: Evidence regarding using acetylsalicylic acid (aspirin) for the prevention of cardiovascular (CV) events in …
Impact of acetylsalicylic acid on primary prevention of cardiovascular diseases: A meta-analysis of randomized trials.
Upadhaya S, Madala S, Baniya R, Saginala K, Khan J. Upadhaya S, et al. Eur J Prev Cardiol. 2019 May;26(7):746-749. doi: 10.1177/2047487318816387. Epub 2018 Nov 30. Eur J Prev Cardiol. 2019. PMID: 30861689
Numerous studies have investigated use of acetylsalicylic acid (ASA) for prevention of cardiovascular deaths. The vast majority of the work in this area has focused on secondary prevention. ...
Numerous studies have investigated use of acetylsalicylic acid (ASA) for prevention of cardiovascular deaths. The vast majorit …
The influence of acetylsalicylic acid on bone regeneration: systematic review and meta-analysis.
de Souza Rendohl E, Miziara LNB, Pimentel AC, Sendyk WR, Santiago Junior JF, Marão HF. de Souza Rendohl E, et al. Br J Oral Maxillofac Surg. 2021 Dec;59(10):E1-E16. doi: 10.1016/j.bjoms.2020.08.051. Epub 2020 Aug 19. Br J Oral Maxillofac Surg. 2021. PMID: 34736809
Acetylsalicylic acid (ASA) is commonly used as a non-steroidal anti-inflammatory drug that interferes with multiple biological pathways. ...
Acetylsalicylic acid (ASA) is commonly used as a non-steroidal anti-inflammatory drug that interferes with multiple biological …
Meta-Analysis of Acetylsalicylic Acid Desensitization in Patients With Acute Coronary Syndrome.
Chopra AM, Díez-Villanueva P, Córdoba-Soriano JG, Lee JKT, Al-Ahmad M, Ferraris VA, Mehta M, Kowalski ML. Chopra AM, et al. Am J Cardiol. 2019 Jul 1;124(1):14-19. doi: 10.1016/j.amjcard.2019.03.047. Epub 2019 Apr 10. Am J Cardiol. 2019. PMID: 31027657
Acetylsalicylic acid (ASA) hypersensitivity represents a clinical challenge in acute coronary syndrome (ACS) patients urgently requiring ASA for antiplatelet therapy. ...A PubMed database search was conducted for articles containing combinations of keywords, "asp …
Acetylsalicylic acid (ASA) hypersensitivity represents a clinical challenge in acute coronary syndrome (ACS) patients urgently …
Acetylsalicylic acid desensitization in patients with coronary artery disease: A comprehensive overview of currently available protocols.
Verdoia M, Barbieri L, Schaffer A, Nardin M, Suryapranata H, De Luca G. Verdoia M, et al. Vascul Pharmacol. 2016 May;80:43-9. doi: 10.1016/j.vph.2015.09.005. Epub 2015 Oct 9. Vascul Pharmacol. 2016. PMID: 26456910 Review.
BACKGROUND: Acetylsalicylic acid (ASA) represents the basis of pharmacological therapy for cardiovascular prevention. ...The rate of ASA discontinuation and major cardiovascular events was extremely low (6.1 and 2.3% respectively). CONCLUSIONS: Aspirin desens …
BACKGROUND: Acetylsalicylic acid (ASA) represents the basis of pharmacological therapy for cardiovascular prevention. ...The r …
Acetylsalicylic Acid Treatment in Patients With Sepsis and Septic Shock: A Phase 2, Placebo-Controlled, Randomized Clinical Trial.
Almeida TML, Freitas FGR, Figueiredo RC, Houly SG, Azevedo LCP, Cavalcanti AB, Damiani LP, Svicero BS, Souza MA, Bustamante CLS, Ramos FJS, Alves RSV, Atallah FC, Jackiu M, Pacheco ES, Schmidt RC, Serra FSC, Tomotani DYV, Zampieri FG, Machado FR; BRICNET. Almeida TML, et al. Crit Care Med. 2025 Feb 1;53(2):e269-e281. doi: 10.1097/CCM.0000000000006564. Epub 2025 Feb 21. Crit Care Med. 2025. PMID: 39982179 Clinical Trial.
We aimed to evaluate whether the use of acetylsalicylic acid (ASA) would reduce the intensity of organ dysfunction in septic patients. ...
We aimed to evaluate whether the use of acetylsalicylic acid (ASA) would reduce the intensity of organ dysfunction in septic p …
Non-steroidal anti-inflammatory drugs and acetylsalicylic acid increase the risk of complications of diverticular disease: a meta-analysis of case-control and cohort studies.
Longo S, Altobelli E, Castellini C, Vernia F, Valvano M, Magistroni M, Mancusi A, Viscido A, Ashktorab H, Latella G. Longo S, et al. Int J Colorectal Dis. 2022 Mar;37(3):521-529. doi: 10.1007/s00384-021-04088-1. Epub 2022 Jan 30. Int J Colorectal Dis. 2022. PMID: 35094111
NSAIDs and acetylsalicylic acid use were also associated with increased risk of CD occurrence (OR 3.13, 95% CI 1.73 to 5.68, P = 0.0002, and OR 1.49, 95% CI 1.02 to 2.17, P = 0.04, respectively). The only study found about AD occurrence showed that NSAIDs use was no …
NSAIDs and acetylsalicylic acid use were also associated with increased risk of CD occurrence (OR 3.13, 95% CI 1.73 to 5.68, P …
Effect of Preoperative Antiplatelet Therapy with Acetylsalicylic Acid on Complications and Recurrence in Patients Requiring Drainage of Chronic Subdural Hematomas: a Systematic Review and Meta-analysis.
Agudelo-Arrieta M, Marin-Navas F, Alonso-Ramirez AC, Taub-Krivoy A, Sierra-Peña JA, Feo-Lee OH, Berbeo-Calderon ME. Agudelo-Arrieta M, et al. Acta Neurochir (Wien). 2025 Jul 25;167(1):205. doi: 10.1007/s00701-025-06605-5. Acta Neurochir (Wien). 2025. PMID: 40711578 Free PMC article.
OBJECTIVE: To assess the effect of preoperative acetylsalicylic acid use on the risk of recurrence and complications in patients undergoing surgical drainage of chronic subdural hematoma (cSDH) in light of the widespread use of acetylsalicylic acid for …
OBJECTIVE: To assess the effect of preoperative acetylsalicylic acid use on the risk of recurrence and complications in patien …
Safety and efficacy of early versus delayed acetylsalicylic acid after surgery for spontaneous intracerebral haemorrhage in China (E-start): a prospective, multicentre, open-label, blinded-endpoint, randomised trial.
Liu Q, Mo S, Wu J, Tong X, Wang K, Chen X, Chen S, Guo S, Li X, Li M, Peng L, Sun X, Wang Y, Sun J, Pu J, Zheng K, Zhang J, Liu Y, Yang Y, Wen Z, Nie X, Feng Y, Lan C, Tang H, Wang N, Li J, Miao Z, Lu X, Ning B, Zhao B, Kang D, Chen X, Zhang Y, Zhang Y, Wang A, Zhu C, Araki Y, Uda K, Yoshimura S, Uchida K, Morimoto T, Yoshioka H, Hasan D, Du R, Levitt MR, Cao Y, Wang S, Zhao J; E-start collaborators. Liu Q, et al. Lancet Neurol. 2024 Dec;23(12):1195-1204. doi: 10.1016/S1474-4422(24)00424-1. Lancet Neurol. 2024. PMID: 39577920 Clinical Trial.
Non-bleeding serious adverse events occurred in 57 (42%) of 134 patients in the early-start group and 57 (42%) of 135 patients in the late-start group. INTERPRETATION: Starting acetylsalicylic acid on the third day after surgery for spontaneous intracerebral haemorr …
Non-bleeding serious adverse events occurred in 57 (42%) of 134 patients in the early-start group and 57 (42%) of 135 patients in the late-s …
Does acetylsalicylic acid or warfarin affect the accuracy of fecal occult blood tests?
Gandhi S, Narula N, Gandhi S, Marshall JK, Farkouh ME. Gandhi S, et al. J Gastroenterol Hepatol. 2013 Jun;28(6):931-6. doi: 10.1111/jgh.12201. J Gastroenterol Hepatol. 2013. PMID: 23517228 Review.
AIM: To asess the accuracy of FOBT in patients taking acetylsalicylic acid (ASA) or warfarin. METHODS: A literature search was conducted for studies that investigated the accuracy of FOBT in patients taking ASA and warfarin. ...
AIM: To asess the accuracy of FOBT in patients taking acetylsalicylic acid (ASA) or warfarin. METHODS: A literature search was …
7,739 results